Peterson Caryn

EVP, Regulatory AffairsGossamer Bio, Inc. (GOSS) · full profile →Form 4 · filed Mar 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
24
0 non-derivative · 24 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2026Grant(A)23K23K
Mar 19, 2026Grant(A)9K9K
Mar 19, 2026Grant(A)19K19K
Mar 19, 2026Grant(A)32K32K
Mar 19, 2026Disposed to issuer(D)506K0
Mar 19, 2026Disposed to issuer(D)440K0
Mar 19, 2026Disposed to issuer(D)375K0
Mar 19, 2026Disposed to issuer(D)125K0
Mar 19, 2026Disposed to issuer(D)158K0
Mar 19, 2026Disposed to issuer(D)158K0
Mar 19, 2026Disposed to issuer(D)127K0
Mar 19, 2026Disposed to issuer(D)21K0
Mar 19, 2026Disposed to issuer(D)19K0
Mar 19, 2026Disposed to issuer(D)23K0
Mar 19, 2026Disposed to issuer(D)9K0
Mar 19, 2026Disposed to issuer(D)32K0
Mar 19, 2026Grant(A)506K506K
Mar 19, 2026Grant(A)440K440K
Mar 19, 2026Grant(A)375K375K
Mar 19, 2026Grant(A)125K125K
Mar 19, 2026Grant(A)158K158K
Mar 19, 2026Grant(A)158K158K
Mar 19, 2026Grant(A)127K127K
Mar 19, 2026Grant(A)21K21K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001857256-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: